[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Impact Factor 2022: 1.4
Cite Score 2022: 2.1
SJR 2022: 0.347
SNIP 2022: 0.545
..
Publication Charge
►Publication Fee
..
In Press
 In Press Articles
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 11, Issue 4 (6-2020) ::
Caspian J Intern Med 2020, 11(4): 403-409 Back to browse issues page
Pre and post chemotherapy evaluation of breast cancer patients: Biochemical approach of serum selenium and antioxidant enzymes
Fatemeh Pakmanesh , Daryoush Moslemi , Soleiman Mahjoub
Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran , smahjoub20@gmail.com
Abstract:   (3639 Views)
Backgrounds: Chemotherapy for treatment of breast cancer uses some drugs to target and destroy the cancer cells. However, most of antineoplastic treatments are non-specific and the innate cells will be damaged. In this study, the effect of Adriamycin/Cytoxan (AC) chemotherapy on status of antioxidant enzymes and Se levels in breast cancer patients was evaluated.
Methods: A prospective study, includes 50 breast cancer patients treated with AC chemotherapy (Adriamycin 60 mg/m2, Cytoxan 600 mg/m2) from July 2016 until March 2017. First sampling was obtained before chemotherapy and the second, after 3 cycles of the intervention. Antioxidant enzyme activities (Catalase, Glutathione Peroxidase, Glutathione Reductase and Superoxide Dismutase) and Selenium (Se) levels in serum were measured by spectrophotometry and atomic absorption methods, respectively. Age, BMI, familial history, stage and grade of cancer, tumor site, type of surgery, Estrogen, Progesterone and HER2 receptors, were recorded from each patient. Paired-t test was employed for comparing the data before and after chemotherapy. Age and disease stages were compared by independent t-test.
Results: After 3 courses of chemotherapy, a significant decrease was observed in antioxidant enzymes and also Se (P<0.001). These studied indices were not significant in different age groups (≤48, >48) and stages of disease (early, advanced).
Conclusions: Our findings show that the AC chemotherapy in the breast cancer patients result in drastic changes in oxidant/antioxidant system of the body, specially reduction of Se levels and antioxidant enzymes activities. However, it seems that these changes are not necessarily dependent on the age and disease stage.
Keywords: Breast cancer, Chemotherapy, Catalase, Glutathione Peroxidase, Glutathione Reductase, Superoxide Dismutase, Selenium.
Full-Text [PDF 320 kb]   (841 Downloads)    
Type of Study: Original Article | Subject: Biochimestry
Received: 2019/10/15 | Accepted: 2020/03/1 | Published: 2017/07/15
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Pakmanesh F, Moslemi D, Mahjoub S. Pre and post chemotherapy evaluation of breast cancer patients: Biochemical approach of serum selenium and antioxidant enzymes. Caspian J Intern Med 2020; 11 (4) :403-409
URL: http://caspjim.com/article-1-2082-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 4 (6-2020) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.05 seconds with 40 queries by YEKTAWEB 4645